Medical and Science
Tinkering at the edges of reform won’t cut it: National Health and Medical Research Strategy
Australia’s health and medical research community has welcomed the release of the draft National Health and Medical Research Strategy, with […]
MoreMedical and Science
AstraZeneca and IMRA put female students on the frontline of science and surgery
AstraZeneca and the International Medical Robotics Academy (IMRA) are reshaping the future of women in science and medicine, with two […]
MoreMedical and Science
Independent MP backs Research Australia and AAMRI over ‘missing’ MRFF millions
Dr Monique Ryan MP, Independent Federal Member for Kooyong, has reignited concerns over the Federal Government’s distribution of the Medical […]
MoreMedical and Science
Novo Nordisk launches Prize to spotlight the next generation of women in science
Novo Nordisk has launched the Marie Krogh Young Women in Science Prize, opening applications to early and mid-career women in […]
MoreMedical and Science
Balancing the scales: Why are we missing the mark on diabetes?
As Australia marks National Science Week, two of the nation’s leading voices in diabetes research and policy sit down to […]
MoreMedical and Science
Bridging the bench and boardroom: Rethinking innovation in aggressive breast cancer
Coinciding with National Science Week podcast, Andrew Parry, Associate Director of Global Medical Strategy & Operations at Gilead Sciences and […]
MoreMedical and Science
Amgen’s race to recharge the pulse of R&D: National Science Week
Science is rarely a straight line. It’s a tangle of breakthroughs and bottlenecks, quiet wins and loud frustrations. Coinciding with […]
MoreMedical and Science
$30M research zeroes in on breast cancer’s lethal second act
In a landmark investment to reduce deaths from recurrent early breast cancer, the National Breast Cancer Foundation (NBCF) has awarded […]
MoreMedical and Science
Calls grow for Australia to unlock global R&D access
Research Australia and Universities Australia are amplifying calls for the government to commit to Horizon Europe, a move requiring significant […]
MoreMedical and Science
MAPA announces leadership transition
The Medical Affairs Professionals of Australasia (MAPA) has announced leadership transition as it continues to build momentum in 2025. Lauren […]
MoreRecent Posts in Pharma, MedTech & Biotech
Merck, Edwards Lifesciences, Daiichi Sankyo and Telix crowned Excellence Awardees: Australian HR Awards
September 3, 2025
in Human Resources
Raising the bar for women to change the game in STEM
September 3, 2025
in Medical and Science
Making it personal: Rare cancer voices force health policy inequities into the spotlight
September 3, 2025
in News - Pharmaceuticals
The biosimilars dilemma: Will savings fund innovation or vanish into the budget black hole?
September 2, 2025
in News - Pharmaceuticals
Senators fire sharp criticism at Labor Government inertia on HTA Review
September 2, 2025
in News - Pharmaceuticals
World-first DNA study puts prevention in focus, while government delay continues on promised legislation
September 2, 2025
in News - MedTech & Diagnostics
CEO roundtable to tackle private health deadlock
September 1, 2025
in News - MedTech & Diagnostics
Rare cancer patients pay the price of policy paralysis: New report
September 1, 2025
in News - Pharmaceuticals
Follow Us
Partner with us
Human Resources
Merck, Edwards Lifesciences, Daiichi Sankyo and Telix crowned Excellence Awardees: Australian HR Awards
Merck, Edwards Lifesciences, Daiichi Sankyo, and Telix Pharmaceuticals have emerged as Excellence Awardees at the Australian HR Awards, highlighting their […]
MoreMedical and Science
Raising the bar for women to change the game in STEM
Research Australia and AbbVie joined forces to ignite a spark in Australia’s next generation of female STEM leaders through the […]
MoreNews - Pharmaceuticals
Making it personal: Rare cancer voices force health policy inequities into the spotlight
“How will you make it personal?” That was the unflinching question thrown at policymakers, industry, patients and clinicians during Rare […]
MoreNews - Pharmaceuticals
The biosimilars dilemma: Will savings fund innovation or vanish into the budget black hole?
Australia is standing at a crossroads in its approach to biosimilars, and two leading voices are cutting through the noise […]
More